Dimenhydrinate and Foot deformity - a phase IV clinical study of FDA data

Summary:

Foot deformity is reported as a side effect among people who take Dimenhydrinate (dimenhydrinate), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Gravol, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Foot deformity when taking Dimenhydrinate. It is created by eHealthMe based on reports of 6,546 people who have side effects when taking Dimenhydrinate from the FDA, and is updated regularly.

What is Dimenhydrinate?

Dimenhydrinate has active ingredients of dimenhydrinate. It is often used in nausea. eHealthMe is studying from 6,644 Dimenhydrinate users. Check the latest studies of Dimenhydrinate.

What is Foot deformity?

Foot deformity (functional disability of foot) is found to be associated with 912 drugs and 707 conditions by eHealthMe. Check the latest studies of Foot deformity.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

6,546 people reported to have side effects when taking Dimenhydrinate.
Among them, 14 people (0.21%) have Foot deformity.

Could Dimenhydrinate cause Foot deformity?

Among these 14 people:

How long have people been on Dimenhydrinate when they have Foot deformity? *

What is the gender of people who have Foot deformity when taking Dimenhydrinate? *

female: 100 %
male: 0.0 %

What is the age of people who have Foot deformity when taking Dimenhydrinate? *

What are other drugs people take besides Dimenhydrinate? *

What are other side effects people have besides Foot deformity? *

Pain: 14 people, 100.00%
Itching: 11 people, 78.57%
Infusion Site Pruritus (severe itching at infusion site): 11 people, 78.57%
Infusion Site Induration: 11 people, 78.57%
Weight Decreased: 11 people, 78.57%
Infusion Site Erythema (reddening of the skin at infusion site): 11 people, 78.57%
Blepharitis (chronic inflammation of the eyelid): 11 people, 78.57%
Heart Rate Decreased: 11 people, 78.57%
Skin Erosion (a discontinuity of the skin): 11 people, 78.57%
Exostosis (formation of new bone on the surface of a bone): 11 people, 78.57%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 11 people, 78.57%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 3 people, 21.43%
Erysipelas (bacterial skin infection): 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Dimenhydrinate and have Foot deformity?

- Check whether Foot deformity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dimenhydrinate:

Dimenhydrinate (6,644 reports)

Foot deformity treatments and more:

Foot deformity (14,397 reports)

Browse all side effects of Dimenhydrinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Foot deformity:

Foot deformity (912 drugs)

Browse all the conditions that are associated with Foot deformity:

Foot deformity (707 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dimenhydrinate (the active ingredients of Dimenhydrinate) and Dimenhydrinate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.